NNNN Icon

$NNNN

$NNNN

Anbio Biotechnology

Anbio Biotechnology is a medical device company. It is focused on developing and manufacturing a range of in-vitro diagnostic (IVD) products. The company was founded on July 27, 2021 and is headquartered in Frankfurt, Germany.

Stocks

Total Asset Value

$668

Holders

1

Monthly Transfer Volume

$563.40

Anbio Biotechnology Metrics

Tokenized Public Stocks

10 Total